Admission Serum Iron as an Independent Risk Factor for Postoperative Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage: A Propensity-Matched Analysis

This study aimed to investigate the association between serum iron (SI) and postoperative delayed cerebral ischemia (DCI) following aneurysmal subarachnoid hemorrhage (aSAH). We retrospectively analyzed 985 consecutive adult patients diagnosed with aSAH. Demographic, clinical, and laboratory data were recorded. Univariate and multivariate analyses were employed to assess the association between SI and DCI. Propensity-score matching (PSM) analysis was implemented to reduce confounding. Postoperative DCI developed in 14.38% of patients. Lower SI upon admission was detected in aSAH patients with severe clinical conditions and severe aSAH. SI was negatively correlated with WFNS grade (r = −0.3744, p < 0.001) and modified Fisher (mFisher) grade (r = −0.2520, p < 0.001). Multivariable analysis revealed lower SI was independently associated with DCI [odds ratios (OR) 0.281, 95% confidence interval (CI) 0.177–0.448, p < 0.001], while WFNS grade and mFisher grade were not. The receiver-operating characteristics (ROC) curve analysis of SI for DCI gave an area under the curve (AUC) of 0.7 and an optimal cut-off of 7.5 μmol/L (95% CI 0.665 to 0.733, p < 0.0001). PSM demonstrated the DCI group had a significantly lower SI than the non-DCI group (10.91 ± 6.86 vs. 20.34 ± 8.01 μmol/L, p < 0.001). Lower SI remained a significant independent predictor for DCI and an independent poor prognostic factor of aSAH in multivariate analysis (OR 0.363, 95% CI 0.209–0.630, p < 0.001). The predictive performance of SI for poor outcome had a corresponding AUC of 0.718 after PSM. Lower SI upon admission is significantly associated with WFNS grade, mFisher grade, and predicts postoperative DCI and poor outcome at 90 days following aSAH.

[1]  K. Hatton,et al.  MicroRNAs as Biomarkers for Predicting Complications following Aneurysmal Subarachnoid Hemorrhage , 2021, International journal of molecular sciences.

[2]  C. Scherfler,et al.  Intracerebral Iron Accumulation may be Associated with Secondary Brain Injury in Patients with Poor Grade Subarachnoid Hemorrhage , 2021, Neurocritical Care.

[3]  B. Hoh,et al.  Pathophysiology of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: A Review , 2021, Journal of the American Heart Association.

[4]  Marcey Osgood,et al.  Aneurysmal Subarachnoid Hemorrhage: Review of the Pathophysiology and Management Strategies , 2021, Current Neurology and Neuroscience Reports.

[5]  Xinyan Wu,et al.  The Role of the Blood Neutrophil-to-Lymphocyte Ratio in Aneurysmal Subarachnoid Hemorrhage , 2021, Frontiers in Neurology.

[6]  M. Simon,et al.  Interleukin 6 and Aneurysmal Subarachnoid Hemorrhage. A Narrative Review , 2021, International journal of molecular sciences.

[7]  Xinlong Ma,et al.  Associations between C-reactive protein and white blood cell count, occurrence of delayed cerebral ischemia and poor outcome following aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis , 2021, Acta Neurologica Belgica.

[8]  Daisuke Shimbo,et al.  Acute systematic inflammatory response syndrome and serum biomarkers predict outcomes after subarachnoid hemorrhage , 2020, Journal of Clinical Neuroscience.

[9]  D. Weeks,et al.  Genetic Variability in the Iron Homeostasis Pathway and Patient Outcomes After Aneurysmal Subarachnoid Hemorrhage , 2020, Neurocritical Care.

[10]  Lei Zhou,et al.  Serum Alkaline Phosphatase Level is Associated with Angiographic Vasospasm, Delayed Cerebral Ischemia-Caused Clinical Deterioration, and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage , 2019, Neurocritical care.

[11]  S. Blackburn,et al.  Inflammation in delayed ischemia and functional outcomes after subarachnoid hemorrhage , 2019, Journal of Neuroinflammation.

[12]  C. Deutsch,et al.  Serum Iron Analytes in Healthy and Diseased Florida Manatees (Trichechus manatus latirostris). , 2019, Journal of comparative pathology.

[13]  M. Lawton,et al.  Global brain inflammation in stroke , 2019, The Lancet Neurology.

[14]  D. Weeks,et al.  Genetic Variability and Trajectories of DNA Methylation May Support a Role for HAMP in Patient Outcomes After Aneurysmal Subarachnoid Hemorrhage , 2019, Neurocritical Care.

[15]  D. Kang,et al.  Lower Iron Levels Predict Acute Hydrocephalus Following Aneurysmal Subarachnoid Hemorrhage. , 2019, World neurosurgery.

[16]  Wei Liu,et al.  Tetramethylpyrazine Nitrone Reduces Oxidative Stress to Alleviate Cerebral Vasospasm in Experimental Subarachnoid Hemorrhage Models , 2019, NeuroMolecular Medicine.

[17]  T. Cai,et al.  Decreased Total Iron Binding Capacity May Correlate with Ruptured Intracranial Aneurysms , 2019, Scientific Reports.

[18]  Soojin Park,et al.  Admission neutrophil–lymphocyte ratio predicts delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage , 2019, Journal of NeuroInterventional Surgery.

[19]  D. Verbaan,et al.  Induced Hypertension in Preventing Cerebral Infarction in Delayed Cerebral Ischemia After Subarachnoid Hemorrhage , 2018, Stroke.

[20]  R. Macdonald,et al.  Anemia After Aneurysmal Subarachnoid Hemorrhage Is Associated With Poor Outcome and Death , 2018, Stroke.

[21]  S. Blackburn,et al.  Haemoglobin scavenging in intracranial bleeding: biology and clinical implications , 2018, Nature Reviews Neurology.

[22]  S. Doré,et al.  A Comparison of Pathophysiology in Humans and Rodent Models of Subarachnoid Hemorrhage , 2018, Front. Mol. Neurosci..

[23]  Aditya M. Sharma,et al.  Prevalence of Intracranial Aneurysm in Women With Fibromuscular Dysplasia: A Report From the US Registry for Fibromuscular Dysplasia , 2017, JAMA neurology.

[24]  H. Parlakpınar,et al.  Nebivolol attenuates cerebral vasospasm both by increasing endothelial nitric oxide and by decreasing oxidative stress in an experimental subarachnoid haemorrhage , 2017, British journal of neurosurgery.

[25]  V. Seifert,et al.  Increased risk of delayed cerebral ischemia in subarachnoid hemorrhage patients with additional intracerebral hematoma. , 2017, Journal of neurosurgery.

[26]  D. Conen,et al.  Relationships of iron metabolism with insulin resistance and glucose levels in young and healthy adults. , 2016, European journal of internal medicine.

[27]  S. Blackburn,et al.  Haptoglobin phenotype predicts the development of focal and global cerebral vasospasm and may influence outcomes after aneurysmal subarachnoid hemorrhage , 2015, Proceedings of the National Academy of Sciences.

[28]  M. Ansar,et al.  Iron overload is associated with perihematoma edema growth following intracerebral hemorrhage that may contribute to in-hospital mortality and long-term functional outcome. , 2014, Current neurovascular research.

[29]  L. Koffman,et al.  Brain Iron Metabolism and Brain Injury Following Subarachnoid Hemorrhage: iCeFISH-Pilot (CSF Iron in SAH) , 2014, Neurocritical Care.

[30]  P. Rossini,et al.  Inflammation and iron metabolism in adult patients with epilepsy: Does a link exist? , 2013, Epilepsy Research.

[31]  J. Mocco,et al.  Inflammation, Cerebral Vasospasm, and Evolving Theories of Delayed Cerebral Ischemia , 2013, Neurology research international.

[32]  M. Gutiérrez-Bedmar,et al.  Iron: Protector or Risk Factor for Cardiovascular Disease? Still Controversial , 2013, Nutrients.

[33]  R. Macdonald,et al.  Genetic Elimination of eNOS Reduces Secondary Complications of Experimental Subarachnoid Hemorrhage , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  N. K. de Rooij,et al.  Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: A Systematic Review of Clinical, Laboratory, and Radiological Predictors , 2013, Stroke.

[35]  N. Rothwell,et al.  Inflammation as a predictor for delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage , 2012, Journal of NeuroInterventional Surgery.

[36]  M. Kurukumbi,et al.  Acute Ischemic Stroke Secondary to Iron Deficiency Anemia: A Case Report , 2012, Case reports in neurological medicine.

[37]  H. Pannek,et al.  Spreading convulsions, spreading depolarization and epileptogenesis in human cerebral cortex , 2011, Brain : a journal of neurology.

[38]  R. Macdonald,et al.  Cerebral Infarction After Subarachnoid Hemorrhage Contributes to Poor Outcome by Vasospasm-Dependent and -Independent Effects , 2011, Stroke.

[39]  M. Loftspring Iron and Early Brain Injury after Subarachnoid Hemorrhage , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[40]  Joseph P Broderick,et al.  Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group , 2010, Stroke.

[41]  R. Keep,et al.  Hemoglobin and Iron Handling in Brain after Subarachnoid Hemorrhage and the Effect of Deferoxamine on Early Brain Injury , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[42]  J. Serena,et al.  Iron-Related Brain Damage in Patients With Intracerebral Hemorrhage , 2010, Stroke.

[43]  M. Vermeulen,et al.  Increased Cortisol Levels are Associated with Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage , 2010, Neurocritical care.

[44]  R. D. de Haan,et al.  Effect of Statin Treatment on Vasospasm, Delayed Cerebral Ischemia, and Functional Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis Update , 2010, Stroke.

[45]  Jacqueline Birks,et al.  Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up , 2009, The Lancet Neurology.

[46]  K. Kalantar-Zadeh,et al.  Association of Serum Total Iron-Binding Capacity and Its Changes Over Time with Nutritional and Clinical Outcomes in Hemodialysis Patients , 2009, American Journal of Nephrology.

[47]  M. Mattson,et al.  Iron-deficiency anaemia enhances red blood cell oxidative stress , 2008, Free radical research.

[48]  R. Keep,et al.  Mechanisms of brain injury after intracerebral haemorrhage , 2006, The Lancet Neurology.

[49]  J. García-Erce,et al.  Iron metabolism, inflammation and anemia in critically ill patients. A cross-sectional study. , 2005, Nutricion hospitalaria.

[50]  Yunling E. Du,et al.  Effect of Cisternal and Ventricular Blood on Risk of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage:: The Fisher Scale Revisited , 2001, Stroke.

[51]  S. Juvela Plasma endothelin concentrations after aneurysmal subarachnoid hemorrhage. , 2000, Journal of neurosurgery.

[52]  B. D. Anderson,et al.  Quantitative assessment of blood-brain barrier damage during microdialysis. , 1996, The Journal of pharmacology and experimental therapeutics.

[53]  C. Symonds,et al.  Spontaneous Sub-Arachnoid Hæmorrhage , 1924, Proceedings of the Royal Society of Medicine.

[54]  Jan Claassen,et al.  Loss of Consciousness at Onset of Subarachnoid Hemorrhage as an Important Marker of Early Brain Injury. , 2016, JAMA neurology.

[55]  R. Macdonald,et al.  Delayed neurological deterioration after subarachnoid haemorrhage , 2014, Nature Reviews Neurology.

[56]  K. Fukuo,et al.  Association of low serum iron levels with low-grade inflammation and hyperadiponectinemia in community-living elderly women. , 2013, Journal of atherosclerosis and thrombosis.

[57]  Y. V. van Maercke,et al.  [Subarachnoid hemorrhage]. , 1961, Belgisch tijdschrift voor geneeskunde.